NNOX Nano X Imaging

Nanox to Report First Quarter and Financial Results on May 28, 2024

Nanox to Report First Quarter and Financial Results on May 28, 2024

PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2024, before market open on Tuesday, May 28, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link:  . You may access the live webcast of the conference call by using the following link: . The link will also be posted in the Investor Relations section of the Nanox website at .

About Nanox

Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit 

Contacts

Media Contact:

Ben Shannon

ICR Westwicke

Investor Contact:

Mike Cavanaugh

ICR Westwicke



EN
20/05/2024

Underlying

NNOXNano X Imaging

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nano X Imaging

 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Signs Distribution Agreement with Imperial Imaging Technology to...

Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast Agreement with Imperial Imaging strengthens Nanox’s commercial rollout across the orthopedic-rich segment in six U.S. Southeast states. Distribution Agreement Supports U.S. Market Expansion PETACH TIKVA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its US-based subsidiary, Nanox Impact Inc. has signed a new distribution agreement with LLC, a Georgia based provider of diagnostic imagin...

March 3, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution A...

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market PETACH TIKVA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Intec SRL, an Argentina-based medical device distributor with more than 35 years of experience delivering advanced imaging technologies to healthcare providers nationwide. The is a multi-source d...

February 19, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present ...

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026 Live demonstrations of the Nanox.ARC will feature at the ECR booth #425 in Hall X4Oral presentation by Dr. Nogah Shabshin to present data on potential role of digital tomosynthesis in lung cancer screeningOral presentation by Dr. Orit Wimpfheimer to explore how Nanox AI transforms routine CT scans into tools for early detection of cardiovascular disease, osteoporosis and fatty liver diseasePoster presentations to highlight new clinical data from ADOPT study featuring AI bone solution PETAC...

February 17, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Ca...

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US The newly cleared capability provides radiologists with a 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation PETACH TIKVA, Israel – February 3 – (“Nanox” or the “Company”) today announced that the United States Food and Drug Administration (FDA) has gran...

February 3, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in ...

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina Collaboration with Adriamed drives commercial expansion and strengthens Nanox’s regional leadership Engagement supports continued growth across multiple European markets, following recent collaborations in Greece, Romania, and PETACH TIKVA, ISRAEL – January 14, 2026 – (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a new collaboration with (“Adriamed”), a Belgrade-based medical device distributor serving healthcare providers a...

January 14, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch